Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Topical Hemostasis in Minimally Invasive Surgery
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Advances in Immuno-Oncology Therapy in Urothelial Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    IBD Fellow Training in US
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
    Release Date:
    Partner: ACCC
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Imaging Diagnostics for Differentiating Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Improving Treatment Environment for Chronic Myeloid Leukemia (CML)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
    Atrial Fibrillation and Venous Thromboembolism (excluding United States)
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    China Breast Cancer Landscape – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China